US Patent Issued to GENEXINE on July 15 for "Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein" (South Korean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,677, issued on July 15, was assigned to GENEXINE INC. (Seongnam-si, South Korea).

"Virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein" was invented by Moon Cheol Kang (Pohang-si, South Korea), Young Woo Choi (Pohang-si, South Korea), Donghoon Choi (Yongin-si, South Korea) and Young Chul Sung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion pr...